Filter Results:
(270)
Show Results For
- All HBS Web
(588)
- People (2)
- News (197)
- Research (270)
- Multimedia (2)
- Faculty Publications (129)
Show Results For
- All HBS Web
(588)
- People (2)
- News (197)
- Research (270)
- Multimedia (2)
- Faculty Publications (129)
Sort by
- 20 Sep 2011
- First Look
First Look: September 20
Hospital: Cardiac Care for the Poor (B) Tarun Khanna and Tanya BijlaniHarvard Business School Supplement 712-402 Narayana Hrudayalaya (NH) has expanded into a multi-specialty health city in Bangalore and has... View Details
Keywords: Sean Silverthorne
- 28 Feb 2019
- Cold Call Podcast
Pursuing Precision Medicine at Intermountain Healthcare
- 26 Mar 2019
- First Look
New Research and Ideas, March 26, 2019
Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55886 Can Biometric Tracking Improve Healthcare Provision and Data Quality? Experimental Evidence from Tuberculosis Control in India By:... View Details
Keywords: Dina Gerdeman
- August 2006 (Revised September 2006)
- Case
Scopie's Enlarged Gland Shrinker
Describes a firm that markets a laser for a fictional problem. Asks readers to evaluate Scopie's marketing and production strategy (it plans to start in India and then expand to the United States) and its long-term viability. View Details
Herzlinger, Regina E. "Scopie's Enlarged Gland Shrinker." Harvard Business School Case 307-035, August 2006. (Revised September 2006.)
- March 2025
- Case
Niramai: An AI Solution to Save Lives
By: Rembrand Koning, Maria P. Roche and Kairavi Dey
Founded in 2017, Niramai developed Thermalytix, a breast cancer screening tool. Thermalytix used a high-resolution thermal sensing device and machine learning algorithms to analyze thermal images and detect tumors. Its patented solution leveraged big data analytics,... View Details
- 26 Jan 2015
- Research & Ideas
National Health Costs Could Decrease if Managers Reduce Work Stress
unit. "But traditionally in the US we have not placed a lot of emphasis on the role of workplace stress in the high cost of health care." In recent years, General... View Details
- 13 Mar 2007
- First Look
First Look: March 13, 2007
India Authors:A. Banerjee, Shawn A. Cole, E. Duflo, and L. Linden Periodical:Quarterly Journal of Economics (forthcoming). (August 2007) Abstract This paper presents the results of two randomized experiments conducted View Details
Keywords: Martha Lagace
- 2025
- Working Paper
Mammography - Early Detection, Precise Diagnoses: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how the development of x-ray-based techniques and equipment (“mammography”) led to widespread screening for breast cancer and enabled “minimally invasive” biopsies of breast tumors. Specifically, we chronicle how: 1) new protocols and... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Mammography - Early Detection, Precise Diagnoses: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-002, July 2019. (Revised January 2025.)
- 20 Jul 2010
- First Look
First Look: July 20
Tahilyani, and Anjali RainaHarvard Business School Case 110-001 The case focuses on how Pratham, a non-governmental organization, provided quality education to underprivileged children in India by... View Details
Keywords: Martha Lagace
- 2023
- Article
Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma
By: Nazlı Sönmez, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell and Kamalini Ramdas
In Shared Medical Appointments (SMAs), patients with similar conditions meet the physician together and each receives one-on-one attention. SMAs can improve outcomes and physician productivity. Yet privacy concerns have stymied adoption. In physician-deprived nations,... View Details
Sönmez, Nazlı, Kavitha Srinivasan, Rengaraj Venkatesh, Ryan W. Buell, and Kamalini Ramdas. "Evidence from the First Shared Medical Appointments (SMAs) Randomised Controlled Trial in India: SMAs Increase the Satisfaction, Knowledge, and Medication Compliance of Patients with Glaucoma." e0001648. PLoS Global Public Health 3, no. 7 (2023).
- 09 Feb 2010
- First Look
First Look: Feb. 9
"high-end" firm that is expected to care only for its most quality-sensitive customers can have an advantage in introducing a product relative to a firm that is expected to be more widely... View Details
Keywords: Martha Lagace
- 22 May 2020
- In Practice
Post-COVID Health Care: More Screens, Less Red Tape?
The coronavirus crisis forced health care providers to mobilize in ways few could have predicted six months ago, revealing not only the system’s weaknesses but its profound ingenuity. Within weeks, providers... View Details
Keywords: by Danielle Kost
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Several conclusions arise than can help inform the design of care delivery platforms for HIV/AIDS. Download the paper: http://www.hbs.edu/research/pdf/09-093.pdf Cases & Course MaterialsAccenture's War for Talent View Details
Keywords: Martha Lagace
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- January 2023
- Case
Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery
By: Regina Herzlinger and Brian Walker
What should a successful executive (HBS Baker Scholar) assess as her next move as the CEO of a firm with a promising and yet uncertain new drug? Amy Burroughs’ mandate to successfully commercialize Cleave Therapeutics’ drug for a cancer with no current successful... View Details
Keywords: Product Development; Leadership; Health Testing and Trials; Research and Development; Risk and Uncertainty; Financial Condition; Partners and Partnerships; Pharmaceutical Industry
Herzlinger, Regina, and Brian Walker. "Cleave Therapeutics: Taking a Risk on Oncology Drug Discovery." Harvard Business School Case 323-045, January 2023.
- 20 Jun 2017
- First Look
First Look at New Research and Ideas, June 20
School Case 317-103 PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World PharmAccess is an Amsterdam-based NGO working to support the development of the private health View Details
Keywords: Sean Silverthorne
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Leadership; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- March 2007 (Revised February 2010)
- Case
Fabindia Overseas Pvt. Ltd.
By: Mukti Khaire and Prabakar (PK) Kothandaraman
Fabindia is a for-profit Indian retail company with the stated mission of providing employment to weavers and traditional handicraft artisans in rural India. Established in 1960 as an exporter of home furnishings, Fabindia has grown as a consumer-facing retailer of... View Details
Keywords: Business Model; For-Profit Firms; Growth and Development Strategy; Supply Chain; Mission and Purpose; Expansion; Retail Industry; India
Khaire, Mukti, and Prabakar (PK) Kothandaraman. "Fabindia Overseas Pvt. Ltd." Harvard Business School Case 807-113, March 2007. (Revised February 2010.)
- 2024
- Working Paper
Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances
By: Amar Bhidé, Srikant M. Datar and Katherine Stebbins
This case history describes how endoscopy transformed the diagnosis of ulcers, cancerous polyps, and other alimentary canal diseases and enabled “minimally invasive” surgeries to treat such diseases. Specifically, we chronicle how: 1) flexible glass fiber endoscopes... View Details
Keywords: Health Care and Treatment; Technological Innovation; Innovation Strategy; Technology Adoption; Collaborative Innovation and Invention; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhidé, Amar, Srikant M. Datar, and Katherine Stebbins. "Gastrointestinal Endoscopy--Without Cutting In: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 20-005, July 2019. (Revised May 2024.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Care and Treatment; Business Model; Production; Business Strategy; Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)